Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 4/2021

Ausgabe 4/2021

Inhaltsverzeichnis ( 13 Artikel )

19.01.2021 | Review Article | Ausgabe 4/2021

The role of the glutamine transporter ASCT2 in antineoplastic therapy

Estefânia Teixeira, Cláudia Silva, Fátima Martel

04.01.2021 | Original Article | Ausgabe 4/2021

Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approach

Sumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem, Dale Miles, Rajeev M. Menon, John P. Gibbs

04.01.2021 | Original Article | Ausgabe 4/2021 Open Access

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors

Felipe K. Hurtado, Filippo de Braud, Javier De Castro Carpeño, Maria Jose de Miguel Luken, Ding Wang, Jeffrey Scott, Yvonne Y. Lau, Tracey McCulloch, Morten Mau-Sorensen

05.01.2021 | Original Article | Ausgabe 4/2021

Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition

Xiaofeng Shen, Xiaochen Sun, Hua Chen, Binjie Lu, Yuanyuan Qin, Chenxi Zhang, Guoqiang Liang, Jiangping Wang, Pengfei Yu, Li Su, Qihan Ma, Yuwei Li

08.01.2021 | Original Article | Ausgabe 4/2021

Population pharmacokinetic model development and exposure–response analysis of vincristine in patients with malignant lymphoma

Toshiaki Igarashi, Shinji Kishi, Naoko Hosono, Takashi Higashi, Takahiro Iwao, Ryoichi Yano, Hitoshi Tsukamoto, Nobuyuki Goto, Takahiro Yamauchi, Takanori Ueda

08.01.2021 | Original Article | Ausgabe 4/2021 Open Access

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

Dongwoo Kang, Elizabeth Ludwig, David Jaworowicz, Hannah Huang, Jill Fiedler-Kelly, Jorge Cortes, Siddhartha Ganguly, Samer Khaled, Alwin Krämer, Mark Levis, Giovanni Martinelli, Alexander Perl, Nigel Russell, Malaz Abutarif, Youngsook Choi, Ophelia Yin

10.01.2021 | Original Article | Ausgabe 4/2021

A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors

Jacob S. Thomas, Anthony B. El-Khoueiry, Barry J. Maurer, Susan Groshen, Jacek K. Pinski, Everardo Cobos, David R. Gandara, Heinz J. Lenz, Min H. Kang, C. Patrick Reynolds, Edward M. Newman

12.01.2021 | Original Article | Ausgabe 4/2021

Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study

Enora Vauléon, Hélène Behal, Loïc Lebellec, Renaud Desbarbieux, Simon Baldacci, Nicolas Simon, Diane Pannier, Marie-Hélène Vieillard, Anthony Turpin

15.01.2021 | Original Article | Ausgabe 4/2021

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

Jaime Feliu, Mónica Jorge Fernández, Teresa Macarulla, Bartomeu Massuti, Ana Albero, José Federico González González, Guillermo Quintero-Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montes, Carmen García Piernavieja, Manuel Valladares-Ayerbes, Ana María López Muñoz, Rebeca Mondéjar Solís, Pilar Vicente, Esther Casado Gonzalez, Irene González Cebrián, Guillermo López-Vivanco

19.01.2021 | Original Article | Ausgabe 4/2021

Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients

Kaito Shibata, Takafumi Naito, Satoshi Hirakawa, Koji Suzuki, Seiji Hosokawa, Hiroyuki Mineta, Junichi Kawakami

20.01.2021 | Original Article | Ausgabe 4/2021

5-Fluorouracil disrupts ovarian preantral follicles in young C57BL6J mice

Juliana Z. Almeida, Laritza F. Lima, Luís A. Vieira, Carolina Maside, Anna C. A. Ferreira, Valdevane R. Araújo, Ana B. G. Duarte, Ramon S. Raposo, Sônia N. Báo, Cláudio C. Campello, Luiz F. S. Oliveira, Thayse P. da Costa, José Garcia Abreu, José R. Figueiredo, Reinaldo B. Oriá

15.02.2021 | Short Communication | Ausgabe 4/2021

Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines

Maud Maillard, Audrey Eche-Gass, Mony Ung, Aurélie Brice, Sabrina Marsili, Marion Montastruc, Florent Puisset, Fabienne Thomas

02.11.2020 | Correction | Ausgabe 4/2021

Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy

Masahito Kotaka, Yoji Saito, Takeshi Kato, Hironaga Satake, Akitaka Makiyama, Yasushi Tsuji, Katsunori Shinozaki, Toshiyoshi Fujiwara, Tsunekazu Mizushima, Yasushi Harihara, Naoki Nagata, Naoto Kurihara, Masahiko Ando, Genichi Kusakawa, Takumi Sakai, Yugo Uchida, Mikihiro Takamoto, Saki Kimoto, Ichinosuke Hyodo

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise